MetroWest Medical Center-Framingham Union Hospital is a clinical research site located in Framingham, Massachusetts, United States 01702.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
MetroWest Medical Center-Framingham Union Hospital has participated in 12 clinical trials with 8 currently active.
Therapeutic areas: Breast Adenocarcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MetroWest Medical Center-Framingham Union Hospital has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MetroWest Medical Center-Framingham Union Hospital has 12 clinical trials on record, with 8 currently active. Their work covers Breast Adenocarcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
Yes — MetroWest Medical Center-Framingham Union Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.